Quadria Capital: Asia’s Top Private Equity Firm Driving Healthcare Innovation

Image
  In a region teeming with economic growth and healthcare challenges, private equity in Asia has emerged as a powerful force for transformation—and Quadria Capital is leading that charge. Rather than simply injecting funds into the system, this independent private equity firm is rewriting the rules of healthcare investment with a strategy that prioritizes growth, innovation, and long-term social impact.   As one of the largest private equity firms focused exclusively on the Asia-Pacific healthcare sector, Quadria Capital is quietly yet profoundly reshaping how healthcare is delivered across Asia . But what makes them different from the typical investor? It’s not just about capital— it's about commitment, capability, and a clear vision for sustainable impact.   A Purpose-Driven Investment Strategy   Quadria Capital sees the Asia as a critical market where the right investments can make a disproportionate difference. From multi-specialty hospitals and pharmaceut...

Indian Healthcare Sector: An Attractive Destination For Private Equity Investment

The Indian healthcare sector plays a major role in the Indian economy in terms of revenue and employment. The sector has been growing at a CAGR of 22% since 2016, generating employment for 4.7 million people directly. Further, the sector can generate 2.7 million additional jobs in India between 2017-22 -- over 500,000 new jobs per year.

There are several factors behind the growth of the Indian healthcare sector such as the aging population, a growing middle class, the rising proportion of lifestyle diseases, increased importance on public-private partnerships, and fast adoption of digital technologies, including telemedicine, etc.

https://www.quadriacapital.com/wp-content/themes/quadria/img/our-approach/approach-banner-bg.jpg


The industry is growing at a tremendous pace attracting privateequity investment owing to its strengthening coverage, services, and increasing expenditure by public and private players. 

  1. ·       The hospital industry in India is witnessing a huge investor demand from both global as well as domestic investors. The hospital industry is expected to reach $132 bn by 2023 from $ 61.8 bn in 2017; growing at a CAGR of 16-17%.
  2. ·       The Indian Medical Tourism market is expected to grow from its current size of $3 bn  to $7-8 bn by 2020
  3. ·       The diagnostics industry in India is currently valued at $4 bn. The share of organized sector is almost 25% in this segment.
  4. ·       The primary care industry is currently valued at $13 bn. The share of organized sector is practically negligible in this case.
  5. ·       Health insurance contributes 20% to the non-life insurance business, making it the 2nd largest portfolio. The gross direct premium income underwritten by health insurance grew 17.16% year-on-year to reach $6.87 Billion in FY20.

All these factors make India’s healthcare industry an attractive destination for private equity investment. Whether it is in the field of hospitals, pharmacy, or diagnostic, India offers an attractive investment opportunity. India also has the opportunity to boost domestic manufacturing of the pharmaceuticals, medical devices industry, with tremendous opportunities for expansion of diagnostic and pathology centers as well as miniaturized diagnostics.

Comments

Popular posts from this blog

Private Equity’s Role in Tackling Global Healthcare Inequalities

The Effect of Private Equity Investment in Asia’s Health Care Sector

Private Equity Firms in India Drive Growth in Healthcare & MedTech